论文部分内容阅读
为确保临床用药安全有效，本实验对市售商品红花进行了系统的生药学鉴定，结果表明：我市流通的红花药材，存在一定的掺伪情况，有效成分含量达不到药典（９０版）标准。
In order to ensure the safe and effective clinical use of drugs, this experiment carried out a systematic pharmacognosy identification of the commercial product safflower. The results showed that: there is a certain degree of adulteration of safflower medicinal materials circulating in our city, and the content of active ingredients does not reach the pharmacopoeia (90). Edition) standard.